Literature DB >> 6325887

S1 mapping of purified nascent transcripts of simian virus 40.

D E Lycan, K J Danna.   

Abstract

We purified nascent simian virus 40 late transcripts by incubating viral transcriptional complexes, isolated from infected BSC-1 cells, in a reaction mixture that contained mercurated CTP; RNA molecules that had incorporated mercurated residues in vitro were isolated by sulfhydrylcellulose affinity chromatography. The nascent RNA was hybridized to an end-labeled HindIII C probe fragment (0.646 to 0.86 map unit), and the hybrids were analyzed by S1 mapping. Most of the products of digestion corresponded to unspliced transcripts with 5' ends mapping at nucleotides 325, 260, and 195, which are positions of the 5' ends of mature, cytoplasmic late mRNA species. In addition, two minor products diagnostic of splicing at the acceptor junctions mapping at nucleotides 556 and 443 were detected. Because the abundance of these products was not diminished by repurifying the nascent RNA through a second round of sulfhydrylcellulose chromatography, these products did not originate from contaminating non-nascent RNA. Moreover, the generation of these products was not affected when a higher salt concentration and lower temperature were used for S1 digestion, conditions that should decrease artifactual cleavage by S1 in A + U-rich regions of colinear hybrids. Therefore, it is likely that some simian virus 40 RNA chains are spliced before release from the template.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325887      PMCID: PMC368769          DOI: 10.1128/mcb.4.4.625-633.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The 5'-terminal leader sequence of late 16 S mRNA from cells infected with simian virus 40.

Authors:  P K Ghosh; V B Reddy; J Swinscoe; P V Choudary; P Lebowitz; S M Weissman
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

2.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Removal of RNase activity from DNase by affinity chromatography on agarose coupled aminophenylphosphoryl-uridine-2' (3')-phosphate.

Authors:  I H Maxwell; F Maxwell; W E Hahn
Journal:  Nucleic Acids Res       Date:  1977-01       Impact factor: 16.971

4.  Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome.

Authors:  R C Mulligan; B H Howard; P Berg
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

5.  Mapping the spliced and unspliced late lytic SV40 RNAs.

Authors:  C J Lai; R Dhar; G Khoury
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

6.  Gaps and duplicated sequences in the leaders of SV40 16S RNA.

Authors:  V B Reddy; P K Ghosh; P Lebowitz; S M Weissman
Journal:  Nucleic Acids Res       Date:  1978-11       Impact factor: 16.971

7.  Characterization of the 5' termini of purified nascent simian virus 40 late transcripts.

Authors:  D E Lycan; K J Danna
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

8.  Precursors of alpha and beta globin messenger RNAs.

Authors:  J Ross; D A Knecht
Journal:  J Mol Biol       Date:  1978-02-15       Impact factor: 5.469

9.  Steps in the processing of Ad2 mRNA: poly(A)+ nuclear sequences are conserved and poly(A) addition precedes splicing.

Authors:  J R Nevins; J E Darnell
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

10.  Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation.

Authors:  R B Hallick; B K Chelm; P W Gray; E M Orozco
Journal:  Nucleic Acids Res       Date:  1977-09       Impact factor: 16.971

View more
  1 in total

1.  The late spliced 19S and 16S RNAs of simian virus 40 can be synthesized from a common pool of transcripts.

Authors:  P J Good; R C Welch; W S Ryu; J E Mertz
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.